ScienceDaily (Feb. 5, 2005) — The microorganism Staphylococcus epidermidis is harmless on human skin, but it is the leading cause of hospital-acquired infections and infections of indwelling medical devices. S. epidermidis is associated with an enormous number of infections in people with prosthetic joints, replacement heart valves, and intravenous catheters, and antibiotic resistance makes it tough to battle. Moreover, the mechanism through which the organism becomes so pathogenic once the protective barrier of the skin is removed remains unclear.

In their study appearing online on February 3 in advance of publication in the March 1 print edition of the Journal of Clinical Investigation, Michael Otto and colleagues from Rocky Mountain Laboratories demonstrate that S. epidermidis secretes an extracellular polymer called poly-gamma-glutamate (PGA) to facilitate growth and ensure survival of the bacteria inside the human host. PGA protects the pathogen from innate host defenses during infection. S. epidermidis is the only human pathogen known to produce PGA other than Bacillus anthracis, but several differences exist in how the two pathogens use PGA to their advantage. PGA is currently used as an antigen for vaccine production against Anthrax

This paper presents PGA as a promising target for drug development aimed at combating these hospital-acquired infections and other illnesses caused by related bacteria.

Adapted from materials provided by Journal Of Clinical Investigation.

Related Stories

Substance Protects Resilient Staph Bacteria (Feb. 4, 2005) — Researchers have identified a promising new target in their fight against a dangerous bacterium that sickens people in hospitals, especially people who receive medical implants such as catheters, ...  > read more

Newly Found Sensing System Enables Certain Bacteria To Resist Human Immune Defenses (Jun. 8, 2007) — Researchers have discovered a survival mechanism in a common type of bacteria that can cause illness. The mechanism lets the bacteria protect itself by warding off attacks from antimicrobial ...  > read more

Preventing Skin Infections: EGF Receptor Activation Prevents Microbes From Going More Than Skin Deep (Jun. 16, 2006) — Our skin not only serves as a physical barrier against infection but skin cells themselves can mount an immune response to kill invading microbes by producing antimicrobial polypeptides. The results ...  > read more

Dual Action Anthrax Vaccine More Effective; New Vaccine Could Also Act As Therapy To Help Those Infected Keep The Bacteria In Check Over Time (Sep. 2, 2003) — Researchers at Harvard Medical School and Brigham and Women's Hospital have created a vaccine that delivers a one-two punch to anthrax and could become a powerful defensive weapon against ...  > read more

Search ScienceDaily

Green and Clean